In the announcement it says that the company has spent significant resources on developing the Indian project.
"The Company has invested considerable resources developing an India project focused on demonstrating
its technologies ahead of commercial rollout."
Where exactly did these resources get invested and why did they cost such a tremendous amount?
Further the announcement states
"ECT is presently focused on delivering its plant upgrade strategy, supported by the current NonRenounceable Entitlement Offer (see announcement 6 December 2019) structured to raise a minimum of
$1.41 million, which closes on 30 January 2020."
How is it that the upgrade strategy only costs 1.41 million to get cash flows of 3 million per annum but the company has not completed this upgrade strategy in prior years when it had significant capital to do so?
- Forums
- ASX - By Stock
- ECT - Q&A Session - India Update
ECT
environmental clean technologies limited.
Add to My Watchlist
0.00%
!
0.3¢

In the announcement it says that the company has spent...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.04M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $80 | 26.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 5622683 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 16651283 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 5622683 | 0.003 |
30 | 66912551 | 0.002 |
23 | 71264054 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 16651283 | 29 |
0.005 | 9399025 | 14 |
0.006 | 3118000 | 5 |
0.007 | 1000000 | 1 |
0.010 | 133333 | 1 |
Last trade - 10.05am 04/07/2025 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online